Venetoclax retreatment of patients with chronic lymphocytic leukemia after a previous venetoclax-based regimen.
作者信息
Thompson Meghan C, Harrup Rosemary A, Coombs Catherine C, Roeker Lindsey E, Pu Jeffrey J, Choi Michael Y, Barr Paul M, Allan John N, Šimkovič Martin, Leslie Lori, Rhodes Joanna, Chong Elise A, Kamdar Manali, Skarbnik Alan, Lansigan Frederick, McCall Brittany, Saja Khalid, Dyer Martin J S, Walter Harriet S, Lefebure Marcus, Thadani-Mulero Maria, Boyer Michelle, Biondo Juliana, Sail Kavita, Manzoor Beenish S, Furman Richard, Bantilan Kurt S, Goy Andre, Feldman Tatyana, Labella Dominic, Schuster Stephen J, Park Jae, Palomba Lia, Zelenetz Andrew, Eyre Toby A, Kater Arnon P, Seymour John F, Mato Anthony R
机构信息
Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY.
Royal Hobart Hospital, Tasmania, Australia.
出版信息
Blood Adv. 2022 Aug 9;6(15):4553-4557. doi: 10.1182/bloodadvances.2022007812.
Zotero 插件